Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2009
11/19/2009WO2009140318A1 Process for the preparation of an alkylene carbonate and an alkylene glycol
11/19/2009WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof
11/19/2009US20090286998 Process for the preparation of alkylene carbonate and/or alkylene glycol
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009CA2724084A1 Process for the preparation of an alkylene carbonate and an alkylene glycol
11/19/2009CA2723988A1 Process for the preparation of alkylene carbonate and/or alkylene glycol
11/18/2009EP2119714A1 Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same
11/18/2009EP2119713A1 2-methyl-3-(3,4-methylenedioxyphenyl)propanal, and method for production thereof
11/18/2009EP1716222B1 Perfuming ingredients capable of imparting woody odors
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/17/2009CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/12/2009WO2009135979A1 Method for obtaining zaragozic acid and derivatives thereof
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281335 Cure Accelerators for Anaerobic Curable Compositions
11/12/2009US20090280499 Method and kit for detecting, or determining 3,4- methylenedioxymethamphetamine
11/11/2009EP1426379B1 Transition metal complex,catalyst for olefin polymerization, and process for producing olefin polymer with the same
11/11/2009EP1339673B1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
11/11/2009CN101575329A Preparation method of tetrahydrothiophene-3-ketone and intermediate
11/11/2009CN100558721C Prepn process of fluoric cyclic carbonate
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009US7615525 Dioxa-tricycloundecane compounds
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090274650 Inhibitors of aspartyl protease
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/03/2009US7612053 7-Substituted fused ring tetracycline compounds
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
10/2009
10/29/2009WO2009132131A1 Amino lipid based improved lipid formulation
10/29/2009WO2009130422A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090271879 Analogues of (-)-picropodophyllin, synthesis and uses thereof
10/29/2009US20090270643 Method for producing an oxygen-containing compound used as fuel additive, in particular in diesel fuels, gasoline, and rapeseed methyl ester
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270288 Alkyl acetal compound, process for producing the same, and lubricating oil composition
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009US20090264660 Process for alkyl aryl sulfide derivatives and new sulfide compounds
10/22/2009US20090263726 Anode and method of manufacturing same, secondary battery and method of manufacturing same, and sulfone compound
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/21/2009CN100551907C Compound in category of aryl methylamino dithio formic ether, preparation method and application
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125606A1 Pai-1 inhibitor
10/15/2009WO2009125594A1 Optically active dibenzazepine derivatives
10/15/2009WO2009124987A1 Process for the preparation of alkylene glycol
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests
10/15/2009CA2720219A1 Process for the preparation of alkylene glycol
10/15/2009CA2720096A1 Pai-1 inhibitor
10/14/2009CN101557020A Cathode and secondary battery
10/14/2009CN101555242A Dibenzocyclooctadiene lignan, preparation method and use thereof
10/14/2009CN101555025A Preparation method of ammonia for coal-fired flue gas desulfurization and denitration by coproduction
10/14/2009CN100548988C Metabolites of ecteinascidin 743
10/14/2009CN100548965C Omega oxyacid with chiral methyl lateral chain
10/13/2009US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601682 Mixtures of 3-(4-methylcyclohex-3-enyl)butyraldehyde and Ambrocenide® and corresponding uses and methods
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/08/2009WO2009123355A2 Cooling sensation agent composition and sensory stimulation agent composition
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090252685 High penetration prodrug compositions of prostaglandins and related compounds
10/08/2009DE102008015756A1 Producing biodiesel comprises e.g. transesterifying triglycerides with methanol, separating biodiesel and glycerin, reacting a part of glycerin to 1-hydroxyacetone or acetone, reacting a part of glycerin with 1-hydroxyacetone or acetone
10/07/2009EP2107056A1 Fluorinated compounds, fluorinated polymers of the fluorinated compounds, and optical or electrical materials using the polymers
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009CN101553485A Process for preparing nebivolol
10/07/2009CN101553479A Process for the production of alkylene carbonate and use of alkylene carbonate thus produced in the manufacture of an alkane diol and a dialkyl carbonate
10/07/2009CN101550127A Two crystal substances of bicycle-ethanol, preparation method, pharmaceutical composition and application thereof
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs
10/06/2009US7598419 Such as N-(Cyanoacetyl)-3,4-dimethoxybenzylamide
10/06/2009US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598294 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy
10/06/2009US7598292 such as {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl )-allylsulfanyl]-phenoxy}-acetic acid, used as peroxisome proliferator-activated receptors modulators for treating or inhibit the progression of dyslipidemia
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009CA2482530C 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/01/2009WO2009120191A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009WO2009118580A2 Gaba analogs, compositions, and methods for manufacturing thereof
10/01/2009WO2009118369A1 Process for the removal of hf from hf containing organic carbonates
10/01/2009WO2009118368A1 Preparation of fluorinated organic carbonates depleted in hf using a specific absorbent
10/01/2009US20090247722 Cyclic alkylene carbonate-derived isocyanate-terminated prepolymers, method for their preparation and their use
10/01/2009US20090247616 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009CA2719624A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009CA2717841A1 Process for the removal of hf from hf containing organic carbonates
09/2009
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009CN101544627A Method for synthesizing cyclic carbonate ester
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009CA2418118C Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 183